Phase 2 clinical trial

September 7, 2018

Sorafenib plus Hycamtin Combo Prolongs Survival in Platinum-resistant Ovarian Cancer, Phase 2 Trial Shows

News

Adding sorafenib, an anti-cancer oral medicine, to Hycamtin (topotecan) chemotherapy slows the time to disease progression or death in women with platinum-resistant ovarian cancer, a Phase 2 trial shows. The ... Read more

August 13, 2018

Phase 2 Trial Shows Dalantercept Has Limited Effectiveness in Ovarian Cancer Patients

News

A Phase 2 clinical trial determined that treatment with dalantercept, an inhibitor of blood vessel maturation, is safe but has limited effectiveness in ovarian cancer patients, none of whom responded to the ... Read more

October 16, 2017October 16, 2017

First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery

News

The pharmaceutical development company NanOlogy has enrolled the first participant in its Phase 2 trial evaluating the safety and effectiveness of NanoPac, a new delivery method for the anti-cancer treatment ... Read more

August 16, 2017August 16, 2017

Trial of Vaccine to Prevent Ovarian Cancer Recurrence Expands to Advanced-stage Patients

News

TapImmune has amended the criteria for patient enrollment in a Phase 2 clinical trial testing its T-cell vaccine, TPIV 200, in women with ovarian cancer. While the study initially aimed to enroll 80 patients, it is ... Read more